-
Mashup Score: 2Featured Articles Archive - 10 month(s) ago
2023 Featured Articles July 13 – Biopsy-Guided Pathological Response Assessment in Breast Cancer is Insufficient: Additional Pathology Findings of the MICRA Trial Citation: van Hemert, A.K.E., van Duijnhoven, F.H., van Loevezijn, A.A. et al. Biopsy-Guided Pathological Response Assessment in Breast Cancer is Insufficient: Additional Pathology Findings of the MICRA Trial. Ann Surg Oncol 30,…
Source: Society of Surgical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Featured Articles Archive - 10 month(s) ago
2023 Featured Articles July 13 – Biopsy-Guided Pathological Response Assessment in Breast Cancer is Insufficient: Additional Pathology Findings of the MICRA Trial Citation: van Hemert, A.K.E., van Duijnhoven, F.H., van Loevezijn, A.A. et al. Biopsy-Guided Pathological Response Assessment in Breast Cancer is Insufficient: Additional Pathology Findings of the MICRA Trial. Ann Surg Oncol 30,…
Source: Society of Surgical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In this Featured Article from @AnnSurgOncol, additional pathology findings of the MICRA trial demonstrate surgical excision remains obligatory until imaging and biopsy techniques improve accuracy. Read the full article: https://t.co/ZUncme4I4b https://t.co/tCGvz5maZ0
-
-
Mashup Score: 0Speaking of SurgOnc® - 10 month(s) ago
Speaking of SurgOnc® is a podcast brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology (SSO). The series is hosted by ASO Deputy Editor Dr. Frederick L. (Rick) Greene, who will expand upon ideas from articles published in the Annals of Surgical Oncology. Once a month, Dr. Greene will … Speaking of SurgOnc® Read More »
Source: Society of Surgical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Rick Greene, MD, and @JesseSelber, MD, MPH, MHCM, FACS, discuss how artificial intelligence can aid surgeons in the care of patients in this latest episode of Speaking of SurgOnc. Listen to the full episode here: https://t.co/SukkP7pBPf https://t.co/LYr9LyG3Cc
-
-
Mashup Score: 0Speaking of SurgOnc® - 10 month(s) ago
Speaking of SurgOnc® is a podcast brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology (SSO). The series is hosted by ASO Deputy Editor Dr. Frederick L. (Rick) Greene, who will expand upon ideas from articles published in the Annals of Surgical Oncology. Once a month, Dr. Greene will … Speaking of SurgOnc® Read More »
Source: Society of Surgical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Rick Greene, MD, discusses with @JesseSelber, MD, MPH, MHCM, FACS, the use of ChatGPT and explores questions regarding the potential of artificial intelligence (AI) - its opportunities, challenges, and possible role in surgery. Listen Now: https://t.co/JnOM2SvPtO @AnnSurgOncol https://t.co/DhDVlrjrVC
-
-
Mashup Score: 0Featured Articles Archive - 10 month(s) ago
2023 Featured Articles July 6 – Surgical Management of Germline Gastrointestinal Stromal Tumor Citation: Kwak, H.V., Tardy, K.J., Allbee, A. et al. Surgical Management of Germline Gastrointestinal Stromal Tumor. Ann Surg Oncol 30, 4966–4974 (2023). https://doi.org/10.1245/s10434-023-13519-y Synopsis: Germline mutations causing gastrointestinal stromal tumors (GISTs) are rare and surgical…
Source: Society of Surgical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In this Featured Article from @AnnSurgOncol, the authors used population-level data to reveal that ambulatory MRM patients were readmitted less often, and the procedure was less expensive in the ambulatory setting. https://t.co/z5TWfu3ftO https://t.co/j4mTulIMLA
-
-
Mashup Score: 0Featured Articles Archive - 10 month(s) ago
2023 Featured Articles July 6 – Surgical Management of Germline Gastrointestinal Stromal Tumor Citation: Kwak, H.V., Tardy, K.J., Allbee, A. et al. Surgical Management of Germline Gastrointestinal Stromal Tumor. Ann Surg Oncol 30, 4966–4974 (2023). https://doi.org/10.1245/s10434-023-13519-y Synopsis: Germline mutations causing gastrointestinal stromal tumors (GISTs) are rare and surgical…
Source: Society of Surgical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
From @AnnSurgOncol: Germline mutations causing gastrointestinal stromal tumors (GISTs) are rare and surgical management is controversial. This article discusses this controversy and highlights key concepts in a patient with a germline KIT 579 deletion. https://t.co/UEa5gUZV9J https://t.co/Cvz1RoTU3Z
-
-
Mashup Score: 0The Landmark Series - 10 month(s) ago
The Annals of Surgical Oncology (ASO) is pleased to announce, The Landmark Series. As described by ASO Editor-in-Chief, Kelly M. McMasters, MD, PhD, “The Landmark Series is designed to trace the origins of current multidisciplinary therapy for each type of solid tumor, and demonstrate the logical progression of clinical trials and other key evidence. It is meant to be an educational resource, for…
Source: Society of Surgical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
During #SarcomaAwarenessMonth, review this @AnnSurgOncol Landmark Series article focusing on managing disseminated appendiceal cancers & reviewing the high-impact retrospective studies that guide current practice. https://t.co/c7KmPB29iY @MeganDelisleMD @SBonvalot @CarolynNessim https://t.co/77PUvpSkgm
-
-
Mashup Score: 0The Landmark Series - 10 month(s) ago
The Annals of Surgical Oncology (ASO) is pleased to announce, The Landmark Series. As described by ASO Editor-in-Chief, Kelly M. McMasters, MD, PhD, “The Landmark Series is designed to trace the origins of current multidisciplinary therapy for each type of solid tumor, and demonstrate the logical progression of clinical trials and other key evidence. It is meant to be an educational resource, for…
Source: Society of Surgical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In this article from the @AnnSurgOncol Landmark Series, the authors describe how the genetics of melanoma has facilitated our understanding of the disease and the application of new therapies. https://t.co/yyxDe6I31d @DKDePeralta @gmboland https://t.co/GjUsvfrBn5
-
-
Mashup Score: 0Membership - 10 month(s) ago
Join SSO and Reap the Rewards of Membership Commit to the SSO mission of improving multidisciplinary patient care by advancing the science, education and practice of cancer surgery worldwide and become a member today. Join Now (I Have an Account) Join Now (I Don’t Have an Account) Join SSO Today Learn about the many benefits … Membership Read More »
Source: Society of Surgical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Network with the top surgical oncologists in the world and contribute to quality care and advancements in cancer treatment. Become a member of the Society of Surgical Oncology today! https://t.co/b0Lu80iUt2 https://t.co/6osxZbUJId
-
-
Mashup Score: 1Featured Articles Archive - 10 month(s) ago
2023 Featured Articles June 29 – Influence of Extraperitoneal Metastases on the Curative-Intent Management of Colorectal Peritoneal Metastases Citation: Schell, F., Kefleyesus, A., Benzerdjeb, N. et al. Influence of Extraperitoneal Metastases on the Curative-Intent Management of Colorectal Peritoneal Metastases. Ann Surg Oncol 30, 4444–4454 (2023). https://doi.org/10.1245/s10434-023-13279-9…
Source: Society of Surgical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
From @AnnSurgOncol: This study investigated histologic organ involvement (HOI) in patients with retroperitoneal liposarcomas. HOI was a frequent finding, supporting the need for multivisceral surgery. https://t.co/agmxkO92jl https://t.co/JJotWQWAj6
-
This featured article from @AnnSurgOncol discusses the finding that the R0 resection rate decreased over time (2009-2019) after pancreatoduodenectomy (PD) for pancreatic cancer in 2955 patients in this nationwide cohort study. Read full article at https://t.co/qXyKFjKQ06 https://t.co/ICzREgvEFc